Metal-organic nanostructures based on sono/chemo-nanodynamic synergy of Ti(x)O(y)/Ru reaction units: for ultrasound-induced dynamic cancer therapy.

基于 Ti(x)O(y)/Ru 反应单元的声/化学-纳米动力学协同作用的金属有机纳米结构:用于超声诱导动态癌症治疗

阅读:9
作者:Jiang Tao, Tang Zixiang, Tian Shumiao, Tang Haitian, Jia Zhekun, Li Fangjian, Qiu Chenyue, Deng Lin, Ke Lang, He Pan, Liu Gang, Chu Chengchao, Xiong Yongfu
Sonodynamic therapy (SDT) exhibits clinical potential for deep-tissue tumor treatment due to its deep tissue penetration and spatiotemporal controllability. Its core mechanism relies on ultrasound-activated sonosensitizers to generate reactive oxygen species (ROS), thereby inducing tumor cell apoptosis. However, conventional sonosensitizers face limitations in ROS yield and tumor-targeting efficiency. In this study, we innovatively designed a multifunctional metal-organic nanosheet (TiZrRu-MON) by hydrothermal coordination of [Ru(bpy)₃](2)⁺ photosensitizing units with TiZr-O clusters, while incorporating Fe(3)⁺ to construct a cascade catalytic system. Experimental results demonstrated that: (1) Fe(3)⁺ lattice doping significantly enhanced charge carrier mobility and ultrasound-triggered (1)O₂ quantum yield via the formation charge transfer channels; (2) The acidic tumor microenvironment activated Fe(3)⁺-mediated Fenton reactions, establishing a positive feedback loop with SDT to synergistically amplify ROS generation; (3) Hyaluronic acid functionalization improved nanosheet internalization in HepG2 tumor cells through CD44 receptor-mediated endocytosis. Remarkably, ultrasound irradiation induced substantial oxidative stress and immunogenic cell death, promoting the release of damage-associated molecular patterns (DAMPs), which elevated the maturation rate of tumor-infiltrating dendritic cells (DCs) and significantly increased the proportion of CD8⁺ T cells. In a mouse subcutaneous tumor model, the system achieved effective tumor suppression with manageable systemic toxicity. This work proposes a metal-ligand coordination strategy to advance the development of high-performance sonosensitizers and immunomodulatory antitumor technologies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。